The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Canine Influenza Vaccine-Global Market Insights and Sales Trends 2024
Synopsis
Canine influenza is influenza occurring in canine animals. Canine influenza is caused by varieties of influenzavirus A, such as equine influenza virus H3N8, which was discovered to cause disease in canines in 2004. Because of the lack of previous exposure to this virus, dogs have no natural immunity to it. Therefore, the disease is rapidly transmitted between individual dogs. Canine influenza may be endemic in some regional dog populations of the United States. It is a disease with a high morbidity but a low incidence of death.
The global Canine Influenza Vaccine market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Canine Influenza Vaccine in various end use industries. The expanding demands from the Vaccination Clinic, Pet Hospital and Others,, are propelling Canine Influenza Vaccine market. H3N2 Vaccine, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the H3N8 Vaccine segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Canine Influenza Vaccine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Canine Influenza Vaccine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Canine Influenza Vaccine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Canine Influenza Vaccine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Canine Influenza Vaccine covered in this report include Bharat Biotech, GSK, Novartis, Merck Animal Health, Roche, Zoetis, CSL Limited, CNBG and LIAONING CHENGDA, etc.
The global Canine Influenza Vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bharat Biotech
GSK
Novartis
Merck Animal Health
Roche
Zoetis
CSL Limited
CNBG
LIAONING CHENGDA
Global Canine Influenza Vaccine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Canine Influenza Vaccine market, Segment by Type:
H3N2 Vaccine
H3N8 Vaccine
Global Canine Influenza Vaccine market, by Application
Vaccination Clinic
Pet Hospital
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Canine Influenza Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Canine Influenza Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Canine influenza is influenza occurring in canine animals. Canine influenza is caused by varieties of influenzavirus A, such as equine influenza virus H3N8, which was discovered to cause disease in canines in 2004. Because of the lack of previous exposure to this virus, dogs have no natural immunity to it. Therefore, the disease is rapidly transmitted between individual dogs. Canine influenza may be endemic in some regional dog populations of the United States. It is a disease with a high morbidity but a low incidence of death.
The global Canine Influenza Vaccine market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Canine Influenza Vaccine in various end use industries. The expanding demands from the Vaccination Clinic, Pet Hospital and Others,, are propelling Canine Influenza Vaccine market. H3N2 Vaccine, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the H3N8 Vaccine segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Canine Influenza Vaccine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Canine Influenza Vaccine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Canine Influenza Vaccine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Canine Influenza Vaccine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Canine Influenza Vaccine covered in this report include Bharat Biotech, GSK, Novartis, Merck Animal Health, Roche, Zoetis, CSL Limited, CNBG and LIAONING CHENGDA, etc.
The global Canine Influenza Vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bharat Biotech
GSK
Novartis
Merck Animal Health
Roche
Zoetis
CSL Limited
CNBG
LIAONING CHENGDA
Global Canine Influenza Vaccine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Canine Influenza Vaccine market, Segment by Type:
H3N2 Vaccine
H3N8 Vaccine
Global Canine Influenza Vaccine market, by Application
Vaccination Clinic
Pet Hospital
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Canine Influenza Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Canine Influenza Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Canine Influenza Vaccine Market Overview
1.1 Canine Influenza Vaccine Product Overview
1.2 Canine Influenza Vaccine Market Segment by Type
1.2.1 H3N2 Vaccine
1.2.2 H3N8 Vaccine
1.3 Global Canine Influenza Vaccine Market Size by Type
1.3.1 Global Canine Influenza Vaccine Market Size Overview by Type (2018-2029)
1.3.2 Global Canine Influenza Vaccine Historic Market Size Review by Type (2018-2023)
1.3.3 Global Canine Influenza Vaccine Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Canine Influenza Vaccine Sales Breakdown by Type (2018-2023)
1.4.2 Europe Canine Influenza Vaccine Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Canine Influenza Vaccine Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Canine Influenza Vaccine Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Canine Influenza Vaccine Sales Breakdown by Type (2018-2023)
2 Global Canine Influenza Vaccine Market Competition by Company
2.1 Global Top Players by Canine Influenza Vaccine Sales (2018-2023)
2.2 Global Top Players by Canine Influenza Vaccine Revenue (2018-2023)
2.3 Global Top Players by Canine Influenza Vaccine Price (2018-2023)
2.4 Global Top Manufacturers Canine Influenza Vaccine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Canine Influenza Vaccine Market Competitive Situation and Trends
2.5.1 Canine Influenza Vaccine Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Canine Influenza Vaccine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Canine Influenza Vaccine as of 2022)
2.7 Date of Key Manufacturers Enter into Canine Influenza Vaccine Market
2.8 Key Manufacturers Canine Influenza Vaccine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Canine Influenza Vaccine Status and Outlook by Region
3.1 Global Canine Influenza Vaccine Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Canine Influenza Vaccine Historic Market Size by Region
3.2.1 Global Canine Influenza Vaccine Sales in Volume by Region (2018-2023)
3.2.2 Global Canine Influenza Vaccine Sales in Value by Region (2018-2023)
3.2.3 Global Canine Influenza Vaccine Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Canine Influenza Vaccine Forecasted Market Size by Region
3.3.1 Global Canine Influenza Vaccine Sales in Volume by Region (2024-2029)
3.3.2 Global Canine Influenza Vaccine Sales in Value by Region (2024-2029)
3.3.3 Global Canine Influenza Vaccine Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Canine Influenza Vaccine by Application
4.1 Canine Influenza Vaccine Market Segment by Application
4.1.1 Vaccination Clinic
4.1.2 Pet Hospital
4.1.3 Others
4.2 Global Canine Influenza Vaccine Market Size by Application
4.2.1 Global Canine Influenza Vaccine Market Size Overview by Application (2018-2029)
4.2.2 Global Canine Influenza Vaccine Historic Market Size Review by Application (2018-2023)
4.2.3 Global Canine Influenza Vaccine Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Canine Influenza Vaccine Sales Breakdown by Application (2018-2023)
4.3.2 Europe Canine Influenza Vaccine Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Canine Influenza Vaccine Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Canine Influenza Vaccine Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Canine Influenza Vaccine Sales Breakdown by Application (2018-2023)
5 North America Canine Influenza Vaccine by Country
5.1 North America Canine Influenza Vaccine Historic Market Size by Country
5.1.1 North America Canine Influenza Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Canine Influenza Vaccine Sales in Volume by Country (2018-2023)
5.1.3 North America Canine Influenza Vaccine Sales in Value by Country (2018-2023)
5.2 North America Canine Influenza Vaccine Forecasted Market Size by Country
5.2.1 North America Canine Influenza Vaccine Sales in Volume by Country (2024-2029)
5.2.2 North America Canine Influenza Vaccine Sales in Value by Country (2024-2029)
6 Europe Canine Influenza Vaccine by Country
6.1 Europe Canine Influenza Vaccine Historic Market Size by Country
6.1.1 Europe Canine Influenza Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Canine Influenza Vaccine Sales in Volume by Country (2018-2023)
6.1.3 Europe Canine Influenza Vaccine Sales in Value by Country (2018-2023)
6.2 Europe Canine Influenza Vaccine Forecasted Market Size by Country
6.2.1 Europe Canine Influenza Vaccine Sales in Volume by Country (2024-2029)
6.2.2 Europe Canine Influenza Vaccine Sales in Value by Country (2024-2029)
7 Asia-Pacific Canine Influenza Vaccine by Region
7.1 Asia-Pacific Canine Influenza Vaccine Historic Market Size by Region
7.1.1 Asia-Pacific Canine Influenza Vaccine Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Canine Influenza Vaccine Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Canine Influenza Vaccine Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Canine Influenza Vaccine Forecasted Market Size by Region
7.2.1 Asia-Pacific Canine Influenza Vaccine Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Canine Influenza Vaccine Sales in Value by Region (2024-2029)
8 Latin America Canine Influenza Vaccine by Country
8.1 Latin America Canine Influenza Vaccine Historic Market Size by Country
8.1.1 Latin America Canine Influenza Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Canine Influenza Vaccine Sales in Volume by Country (2018-2023)
8.1.3 Latin America Canine Influenza Vaccine Sales in Value by Country (2018-2023)
8.2 Latin America Canine Influenza Vaccine Forecasted Market Size by Country
8.2.1 Latin America Canine Influenza Vaccine Sales in Volume by Country (2024-2029)
8.2.2 Latin America Canine Influenza Vaccine Sales in Value by Country (2024-2029)
9 Middle East and Africa Canine Influenza Vaccine by Country
9.1 Middle East and Africa Canine Influenza Vaccine Historic Market Size by Country
9.1.1 Middle East and Africa Canine Influenza Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Canine Influenza Vaccine Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Canine Influenza Vaccine Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Canine Influenza Vaccine Forecasted Market Size by Country
9.2.1 Middle East and Africa Canine Influenza Vaccine Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Canine Influenza Vaccine Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Bharat Biotech
10.1.1 Bharat Biotech Company Information
10.1.2 Bharat Biotech Introduction and Business Overview
10.1.3 Bharat Biotech Canine Influenza Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Bharat Biotech Canine Influenza Vaccine Products Offered
10.1.5 Bharat Biotech Recent Development
10.2 GSK
10.2.1 GSK Company Information
10.2.2 GSK Introduction and Business Overview
10.2.3 GSK Canine Influenza Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.2.4 GSK Canine Influenza Vaccine Products Offered
10.2.5 GSK Recent Development
10.3 Novartis
10.3.1 Novartis Company Information
10.3.2 Novartis Introduction and Business Overview
10.3.3 Novartis Canine Influenza Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Novartis Canine Influenza Vaccine Products Offered
10.3.5 Novartis Recent Development
10.4 Merck Animal Health
10.4.1 Merck Animal Health Company Information
10.4.2 Merck Animal Health Introduction and Business Overview
10.4.3 Merck Animal Health Canine Influenza Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Merck Animal Health Canine Influenza Vaccine Products Offered
10.4.5 Merck Animal Health Recent Development
10.5 Roche
10.5.1 Roche Company Information
10.5.2 Roche Introduction and Business Overview
10.5.3 Roche Canine Influenza Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Roche Canine Influenza Vaccine Products Offered
10.5.5 Roche Recent Development
10.6 Zoetis
10.6.1 Zoetis Company Information
10.6.2 Zoetis Introduction and Business Overview
10.6.3 Zoetis Canine Influenza Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Zoetis Canine Influenza Vaccine Products Offered
10.6.5 Zoetis Recent Development
10.7 CSL Limited
10.7.1 CSL Limited Company Information
10.7.2 CSL Limited Introduction and Business Overview
10.7.3 CSL Limited Canine Influenza Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.7.4 CSL Limited Canine Influenza Vaccine Products Offered
10.7.5 CSL Limited Recent Development
10.8 CNBG
10.8.1 CNBG Company Information
10.8.2 CNBG Introduction and Business Overview
10.8.3 CNBG Canine Influenza Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.8.4 CNBG Canine Influenza Vaccine Products Offered
10.8.5 CNBG Recent Development
10.9 LIAONING CHENGDA
10.9.1 LIAONING CHENGDA Company Information
10.9.2 LIAONING CHENGDA Introduction and Business Overview
10.9.3 LIAONING CHENGDA Canine Influenza Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.9.4 LIAONING CHENGDA Canine Influenza Vaccine Products Offered
10.9.5 LIAONING CHENGDA Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Canine Influenza Vaccine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Canine Influenza Vaccine Industrial Chain Analysis
11.4 Canine Influenza Vaccine Market Dynamics
11.4.1 Canine Influenza Vaccine Industry Trends
11.4.2 Canine Influenza Vaccine Market Drivers
11.4.3 Canine Influenza Vaccine Market Challenges
11.4.4 Canine Influenza Vaccine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Canine Influenza Vaccine Distributors
12.3 Canine Influenza Vaccine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
